Pfizer has stated that they are asking the US regulators to permit the use of their Covid-19 vaccine which could see the pandemic end in the coming months.
A statement released by the company reveals that ‘protection plus a good safety record’ should provide authorization for emergency use which can be given by the Food and Drug Administration before it’s final tests.
Earlier this week, Pfizer and it’s German partner BioNTech revealed that it’s vaccine is 95% effective for prevention of mild to severe Covid-19 cases in a wide studying currently going on.
In the meantime, the FDA are yet to pass a verdict and will hold a public meeting with it’s scientific advisers in a few weeks time.
“We don’t know what that vote’s going to be”, said Norman Baylor, the former FDA vaccine chief.
Also, Dr. Marion Gruber, chief of FDA’s vaccine office said in a statement, “that vaccine is still deemed investigational. It’s not approved yet”.
One would recall that Pfizer and BioNTech stated that only eight people received the actual vaccine out of 170 infected persons detected while the rest had placebo shots for Covid-19 infection in one of their efforts to stop it’s spread.